Latest Health News
WHO Verifies Attacks on Health Care in Middle East Conflict
WHO has confirmed 18 attacks on health facilities in Iran since February 28, killing eight health workers, and 25 in Lebanon, resulting in 16 dead and 29 injured. The ongoing Middle East crisis, now in its third week, is overwhelming fragile health systems with displacement and rising needs.
UN agencies are scaling up emergency aid despite logistical challenges.
UN WHO Releases $2 Million for Health Aid in Lebanon, Iraq, Syria
The UN World Health Organization is allocating another $2 million in emergency funds to bolster health systems amid escalating strikes in Lebanon, Iraq, and Syria. This responds to deepening humanitarian crisis with growing displacement, food insecurity, and pressure on health services.
Aid efforts continue despite security and supply chain disruptions.
MIT Highlights Hyper-Personalized Genetic Medicine via Base Editing
At SXSW 2026, MIT Technology Review named base editing as a top breakthrough, enabling precise correction of single DNA letters to treat rare genetic disorders in infants. This advances hyper-personalized therapies tailored to individual genetics, offering hope for untreatable conditions.
The technology is shifting from labs to scalable medical solutions.
Guardant Health Launches Shield Multi-Cancer Detection Test in Asia
Guardant Health launched the Shield MCD blood test in multiple Asian markets with Manulife, detecting cancers like bladder, colorectal, breast, and others in adults 45+. The methylation-based test aims to enable early multi-cancer screening.
This expands precision oncology access in the region.
Vimgreen's A2AR Antagonist Gets IND Approval for NASH/MASH Therapy
Vimgreen Pharmaceuticals received CDE IND approval for its novel A2AR antagonist to treat NASH/MASH. This adenosine signaling modulator advances to clinical development for liver diseases.
The approval enables upcoming trials for this innovative therapy.
New CAR-T Cell Method Extends Fight Against Disease
Albert Einstein College researchers developed a strategy to engineer CAR-T cells that persist longer in fighting diseases. This innovation improves immune cell durability for cancer and other treatments.
The method shows promise for enhanced therapeutic efficacy.
Johnson & Johnson Reports Positive Erda-iDRS Results in Bladder Cancer
Johnson & Johnson shared promising Phase 1 results for Erda-iDRS (formerly TAR-210) in intermediate-risk non-muscle-invasive bladder cancer. The intravesical therapy demonstrated encouraging first-in-human efficacy.
This advances treatment options for bladder cancer patients.
Radial's Accelerated Deep TMS Treats Depression in Six Days
A landmark study published shows Radial's accelerated Deep TMS protocol treats depression in six days versus months. This revolutionizes non-invasive brain stimulation for mental health.
The research highlights faster patient recovery times.
ImmunoBrain Presents Phase 1b Data for Alzheimer's Immunotherapy
ImmunoBrain will present topline Phase 1b data on its immune checkpoint treatment for Alzheimer's at AD/PD 2026. The therapy targets neurodegeneration via novel immunotherapies.
Results could advance clinical options for Alzheimer's patients.
WHO Strengthens One Health Field Epidemiology in South-East Asia
WHO, with Quadripartite partners, is integrating COHFE into FETPs in Bangladesh, India, and planned for Sri Lanka to build multisectoral capacities. This addresses zoonotic threats, AMR, and emergencies via enhanced surveillance and collaboration.
Efforts align with regional roadmaps for health security.
US and Senegal Sign 2026-2030 Bilateral Health MOU
The United States and Senegal signed a landmark health Memorandum of Understanding for 2026-2030 to advance cooperation. This pact aims to improve health outcomes through joint initiatives.
It marks a key step in bilateral health partnerships.
AHF Urges EU to End Blocking Health Equity Efforts
AIDS Healthcare Foundation Europe plans an advocacy action in Brussels on March 18 against EU blocks on health equity. This addresses barriers to global HIV and health access.
The move seeks policy changes for equitable care.